Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Pepto-Bismol
|
| gptkbp:activities |
reduces inflammation
coats the stomach lining |
| gptkbp:approves |
gptkb:1980s
|
| gptkbp:brand |
gptkb:Kaopectate
gptkb:Pepto-Bismol |
| gptkbp:category |
gptkb:unknown
Category C |
| gptkbp:class |
bismuth compound
salicylate |
| gptkbp:clinical_trial |
studied for efficacy in H. pylori eradication
studied for efficacy in diarrhea studied for efficacy in gastritis studied for efficacy in nausea studied for efficacy in peptic ulcers |
| gptkbp:contraindication |
children with viral infections
allergy to salicylates |
| gptkbp:dissolved |
insoluble in water
soluble in alcohol |
| gptkbp:dosage_form |
oral
suspension chewable tablet |
| gptkbp:duration |
as needed
not exceeding 2 days |
| gptkbp:excretion |
primarily through feces
small amounts in urine |
| gptkbp:federation |
gptkb:drug
|
| gptkbp:historical_event |
developed in the 1900s
popularized in the 1980s |
| https://www.w3.org/2000/01/rdf-schema#label |
bismuth subsalicylate
|
| gptkbp:ingredients |
salicylic acid
bismuth C7 H5 Bi O4 S |
| gptkbp:interacts_with |
gptkb:methotrexate
gptkb:warfarin antibiotics |
| gptkbp:is_available_on |
gptkb:tablet
gptkb:item |
| gptkbp:is_used_for |
treatment of diarrhea
treatment of indigestion treatment of upset stomach |
| gptkbp:lifespan |
gptkb:unknown
|
| gptkbp:mass |
361.33 g/mol
|
| gptkbp:metabolism |
not extensively metabolized
|
| gptkbp:side_effect |
nausea
constipation tinnitus black stool |
| gptkbp:storage |
store at room temperature
keep away from moisture |